Dillard's is a stock, but its analyst coverage is unusually thin. Three firms maintain current 12-month price targets: UBS (Sell, $468), J.P. Morgan (Sell, $519), and Telsey Advisory Group (Hold, $650). The arithmetic mean is about $546, with a range of $468 to $650. Because every one of these targets sits at or below the stock's recent trading price near $600, no meaningful above-price consensus exists, and the minimum-distance rule cannot be satisfied with analyst data.
For that reason, the $700 figure used here is not an analyst price target. It reflects a publicly discussed technical objective: a round-number, psychological resistance level that sits just beneath the stock's 52-week high of $741.98 and near the roughly $695 area where DDS traded in late October. It is a reference point, not a prediction. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
With the stock near $602 in early November 2026, moving to $700 would represent roughly 16% upside. On a strict percentage basis, that is a substantial move rather than a modest drift. The company's fundamentals are a study in contrast: DDS remains highly profitable, with trailing EPS (earnings per share) near $43 and a trailing P/E (price-to-earnings) ratio in the mid-teens, yet revenue has contracted for multiple fiscal years, from about $6.87 billion to roughly $6.6 billion.
A path toward $700 would likely require the stock to reclaim and hold prior breakout zones in the upper $600s before challenging the 52-week high. That, in turn, would depend on evidence that the company can stabilize sales and defend margins, which have moderated from prior peaks.
The 52-week range of $503.06 to $741.98 frames the picture. The $700 area acts as psychological resistance just under the $742 high, while support sits near the $600 round number and the mid-$500s zone. A durable move toward $700 would first require clearing the upper-$600s supply zone that has capped rallies; failure to hold $600 could shift focus back toward the $503 low.
Analyst targets typically reflect a roughly 12-month horizon, and the three DDS targets are no exception, though they diverge widely—from $468 to $650—reflecting disagreement over whether the company can defend its profitability as sales decline. Investors should watch the fiscal third-quarter earnings report due in early-to-mid November, guidance on comparable-store sales and margins, any revisions from the three covering firms, and broader consumer-spending data and rate decisions that influence discretionary retail.
I often rely on Tickeron's AI Daily Buy/Sell Signals to monitor stocks like this one. The tool uses artificial intelligence to scan thousands of equities and ETFs, producing Buy, Sell, or Hold signals based on shifting technical conditions and market dynamics. For a name with thin coverage such as DDS, these signals offer an efficient way to track daily positioning and trend changes alongside conventional analysis.
Can Dillard's (DDS) stock reach $700? The question is best answered with context, not certainty. The $700 level is a technical and psychological objective—not a published analyst consensus—and reaching it from around $602 would require a substantial move of roughly 16%. Supporting the case are Dillard's remarkable profitability, strong balance sheet, and recent earnings beat, while the case against rests on persistent revenue declines, moderating margins, and a broadly bearish analyst stance. With three analysts holding targets at or below the current price and a wide $468-to-$650 range, conviction is clearly limited. The most important near-term catalysts are the upcoming earnings report and any shifts in sales trends or analyst revisions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
DDS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 26 of 28 cases where DDS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 57 cases where DDS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
Following a +6.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where DDS advanced for three days, in 248 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 201 of 264 cases where DDS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.
The 10-day RSI Indicator for DDS moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 51 similar instances where the indicator moved out of overbought territory. In 31 of the 51 cases, the stock moved lower in the following days. This puts the odds of a move lower at 61%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DDS as a result. In 63 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
The Moving Average Convergence Divergence Histogram (MACD) for DDS turned negative on October 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 34 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
DDS moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for DDS crossed bearishly below the 50-day moving average on November 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DDS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
The Tickeron Profit vs. Risk Rating rating for this company is 13 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.
The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.437) is normal, around the industry mean (-9.611). P/E Ratio (13.803) is within average values for comparable stocks, (-121.526). DDS's Projected Growth (PEG Ratio) (0.020) is slightly lower than the industry average of (1.329). DDS has a moderately low Dividend Yield (0.002) as compared to the industry average of (0.032). P/S Ratio (1.532) is also within normal values, averaging (19.276).
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. DDS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 68 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an operator of a chain of departmental stores
Industry DepartmentStores